Cell Separation Instruments

Added: Jun 08, 2017 2:20 pm This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

The National Institute of Health, Clinical Center (CC) intends to award a Firm-Fixed price purchase order to STEMCELL TECHNOLOGIES INC, TUKWILA, WA 98168 on a sole source basis to procure 2 RoboSepTM-S Cell Separator Systems manufactured by STEMCELL Technologies Inc. with capabilities of discrete sample processing and one year service warranty on each system. The samples are used for PCR amplification and it is imperative that these samples have absolutely no contamination that would give inaccurate results and invalidate patient testing. STEMCELL TECHNOLOGIES INC is the only known vendor that can supply the instrument that can handle up to 4 samples for single cell population separation in under one hour and can also meet the requirements that falls under clinical laboratory accreditation guidelines. The purchase order shall not exceed the simplified acquisition threshold.

This acquisition is being conducted under the authority of the FAR Subpart 13.106-1(b)(i) allowing the Contracting Officer (CO) to solicit from one source.

The North American Industry Classification System (NAICS) code for this acquisition is 334516 with a small business standard size of 1,000 employees.

This notice of intent to award is not a request for competitive quotations. Interested concerns capable of providing the same products or services as described in this notice may submit a capability statement outlining their capabilities. No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.

Each response should include the following Business Information:
a. DUNS number and tax identification number.
b. Company Name, address, POC, Phone and Email address
c. Current GSA Schedules or NAICS codes appropriate to this Award.
d. Capability Statement

Comments to this announcement may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Kimala Winfield, kimala.winfield@nih.gov or Barbara Taylor, taylorb@cc.nih.gov by the due date and time marked in this notice.

Responses must be received by June 20, 2017 at 3:00 pm